Nanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria
Leber's hereditary optic neuropathy (LHON) is an ocular mitochondrial disease that involves the impairment of mitochondrial complex I, which is an important contributor to blindness among young adults across the globe. However, the disorder has no available cures, since the approved drug ideben...
Saved in:
| Main Authors: | Yi Wang, Nahui Liu, Lifan Hu, Jingsong Yang, Mengmeng Han, Tianjiao Zhou, Lei Xing, Hulin Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383524003265 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory Chain Complex I Deficiency in Leber Hereditary Optic Neuropathy: Insights from Ophthalmologic and Molecular Investigations in Tunisia
by: Latifa Chkioua, et al.
Published: (2024-11-01) -
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases
by: Jing Chi, et al.
Published: (2025-12-01) -
Diagnostic dilemma: Leber's hereditary optic neuropathy in a 70-year-Old woman
by: Alexandra Pietraszkiewicz, et al.
Published: (2024-12-01) -
Leber’s hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation
by: Golbarg Rahimi, et al.
Published: (2025-02-01) -
Molecular diagnosis of mtDNA syndromes in Egyptian pediatric patients: a hospital-based study
by: Dina Mehaney, et al.
Published: (2024-11-01)